ANNUAL REPORT - HSE
ANNUAL REPORT - HSE
ANNUAL REPORT - HSE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>ANNUAL</strong> <strong>REPORT</strong> <strong>HSE</strong> | FINANCIAL <strong>REPORT</strong> OF THE <strong>HSE</strong> GROUP<br />
For the year 2007<br />
in €<br />
ITEMS Called-up Capital Revenue Revaluation Retained Net profit Consolidation Equity of<br />
capital surplus reserves surplus net or loss equity minority<br />
profit for the adjustment owners TOTAL<br />
Nominal Other or loss period<br />
capital revenue<br />
reserves<br />
As at 01/01/2007 4,824,807 692,999,922 123,162,670 8,507,732 226,597,387 0 5,591 85,631,243 1,141,729,352<br />
Spin-off on 01/01/2007 0 (131,756,737) 0 (19,352) (29,434,985) 0 0 (30,357,828) (191,568,902)<br />
A. As at 01/01/2007 after the spin-off 4,824,807 561,243,185 123,162,670 8,488,380 197,162,402 0 5,591 55,273,415 950,160,450<br />
B. Movements to equity 24,733,982 0 0 27,335,860 (969,690) 83,461,018 (438,900) 6,334,746 140,457,016<br />
a) Subscription of called-up nominal capital 24,733,982 5,984,297 30,718,279<br />
e) Net profit or loss for the period 83,461,018 (314,952) 610,723 83,756,789<br />
f) Equity revaluation adjustments (119,800) 19,548 (100,252)<br />
g) Other increases in components of equity 27,335,860 (969,690) (4,148) (279,822) 26,082,200<br />
C. Movements within equity 0 0 15,156,453 (268,127) (8,682,728) (6,205,598) 0 0 0<br />
a) Allocation of net profit as a component of<br />
equity in accordance with a management 6,205,598 (6,205,598) 0<br />
and supervisory board decision<br />
b) Allocation of net profit to additional<br />
reserves in accordance with a general 8,950,855 (8,950,855) 0<br />
meeting resolution<br />
c) Settlement of loss as<br />
a deduction component of equity (268,127) 268,127 0<br />
D. Movements from equity 0 0 0 (12,885,713) (8,950,854) 0 0 (31,406,697) (53,243,264)<br />
a) Payment of dividends (8,950,854) (8,950,854)<br />
b) Repayment of capital (31,406,697) (31,406,697)<br />
d) Transfer of revaluation surplus<br />
(to operating revenue or finance income) 13,278,034 13,278,034<br />
e) Other decreases in components of equity (26,163,747) (26,163,747)<br />
E. Closing balance for the period 29,558,789 561,243,185 138,319,123 22,670,400 178,559,130 77,255,420 (433,309) 30,201,464 1,037,374,202<br />
* The accompanying notes are an integral part of the consolidated financial statements and should be read in conjunction with them.<br />
152